“We’re currently in the final stages of determining the site location and will work with regulators and other experts to ensure this facility is state-of-the-art and sets a new standard for infant formula production,” Robert Ford, the company’s chairman and CEO, told investors in an earnings call on Wednesday, according to CBS News.
Abbott closed its Abbott, Mich., plant in February because of a contamination issue. The recalled batches spurred a nationwide shortage because the facility was the U.S.’ main source of infant formula. The company resumed operations to normal levels in June, briefly closed a second time because a severe storm caused flooding and then it opened again later that month.
The decision to invest in a new formula-manufacturing facility follows the release of a recent report that showed “this country would benefit from more manufacturing capacity and redundancy,” Mr. Ford said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
